Please enable JavaScript
Powered by Benchmark International Archives - Page 1563 of 1890 - Matribhumi Samachar English
Saturday, January 24 2026 | 03:44:43 PM
Home / International (page 1563)

International

Besra Gold Inc. – Price Query (Reference 107240)

Melbourne, Victoria, Australia–(Newsfile Corp. – March 17, 2025) – Besra Gold Inc. (ASX: BEZ) (“Besra” or the “Company”) refers to the ASX letter dated 17 March 2025 and responds to questions. You can click the link below to read this announcement in full. https://www.besra.com/17-3-2025-bez-response-to-asx-price-query/ About Besra – www.besra.com Besra is …

Read More »

Penbar Capital Ltd. Announces Proposed Qualifying Transaction

Vancouver, British Columbia–(Newsfile Corp. – March 17, 2025) – Penbar Capital Ltd. (TSXV: PEM.P) (the “Company”) is pleased to announce that it has entered into a definitive amalgamation agreement (the “Definitive Agreement”) on March 14, 2025, with Eastport Ventures Inc. (“Eastport”), an arm’s length party, pursuant to which the Company …

Read More »

Avalanche Joins TheBlock as the First Apex Member in Dubai

Dubai, United Arab Emirates–(Newsfile Corp. – March 17, 2025) – Dubai is rapidly emerging as a global leader in blockchain and digital assets, with TheBlock playing a pivotal role in this transformation. In a significant milestone, Avalanche has become the first Apex member of TheBlock, marking a key development in …

Read More »

Hemostemix’s Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial

Calgary, Alberta–(Newsfile Corp. – March 17, 2025) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or “HEM”), an autologous angiogenic stem cell company that has safely treated 498 patients for various forms of cardiovascular disease, pitched the treatment of Vascular Dementia with ACP-01 to Wall Street. “The specificity …

Read More »

Greenbriar Completes Major Water Acquisition for Sage Ranch

Scottsdale, Arizona–(Newsfile Corp. – March 17, 2025) – Greenbriar Sustainable Living Inc. (TSXV: GRB) (OTC Pink: GEBRF) (“Greenbriar” or the “Company”) is pleased to announce that it has reached a binding agreement with Ronnie Strasser to buy 115 acre-feet of adjudicated and deeded water rights for USD $1,250,000. With this …

Read More »

Data I/O to Demonstrate New Unified Programming Platform Strategy at the Upcoming IPC APEX Expo

Newly refreshed manual programmers engineered to seamlessly support design through production and beyond on a single platform Redmond, Washington–(Newsfile Corp. – March 17, 2025) – Data I/O Corporation (NASDAQ: DAIO), the leading global provider of advanced security and data deployment solutions for microcontrollers, security ICs and memory devices, announced the …

Read More »

Searchlight Resources Stakes in the Athabasca Basin

New Staking in Eastern Athabasca Basin2 new claims covering 3,902.8 hectares (39.0 sq km)Within 2 km of anomalous uranium and REE drill holesClose to road and electrical infrastructure Vancouver, British Columbia–(Newsfile Corp. – March 17, 2025) – Searchlight Resources Inc. (TSXV: SCLT) (OTC Pink: SCLTF) (“Searchlight” or the “Company”) is pleased …

Read More »

SuperBuzz Announces TSXV Approval of Consolidation

Toronto, Ontario–(Newsfile Corp. – March 17, 2025) – SuperBuzz Inc. (TSXV: SPZ) (“SuperBuzz” or the “Company”), is pleased to announce that further to its press release dated November 26, 2024, and December 24, 2024, the TSX Venture Exchange (the “Exchange”) has approved the consolidation of the Company’s issued and outstanding …

Read More »

Pacylex Pharmaceuticals Announces the First Acute Myeloid Leukemia (AML) Patient Dosed with Zelenirstat In a New Phase 1/2 Clinical Trial

Edmonton, Alberta–(Newsfile Corp. – March 17, 2025) – Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company and world leader in developing N-myristoyltransferase inhibitors (NMTis) for cancer. Oral zelenirstat is under clinical investigation as a first-in-class targeted therapy for the treatment of hematologic cancers. Pacylex has 27 additional potent NTMis …

Read More »